What is the catalog number for XIAP Rabbit Polyclonal Antibody?

The catalog number for XIAP Rabbit Polyclonal Antibody is orb371699.

What sizes are available for XIAP Rabbit Polyclonal Antibody?

XIAP Rabbit Polyclonal Antibody is available in the following size(s): 100 µg.

Is XIAP Rabbit Polyclonal Antibody in stock?

XIAP Rabbit Polyclonal Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

XIAP Rabbit Polyclonal Antibody

Anti-XIAP Antibody. Tested in WB applications. This antibody reacts with Human.

Product Specifications

Product Name Alternative

E3 ubiquitin-protein ligase XIAP; 6.3.2.-; Baculoviral IAP repeat-containing protein 4; IAP-like protein; ILP; hILP; Inhibitor of apoptosis protein 3; IAP-3; hIAP-3; hIAP3; X-linked inhibitor of apoptosis protein; X-linked IAP; XIAP; API3, BIRC4, IAP3

UniProt

P98170

Reactivity

Human

Cross Reactivity

No cross-reactivity with other proteins

Immunogen

E.coli-derived human XIAP recombinant protein (Position: A15-V244) . Human XIAP shares 89.4% and 90.7% amino acid (aa) sequence identity with mouse and rat XIAP, respectively.

Target

E3 ubiquitin-protein ligase XIAP

Clonality

Polyclonal

Conjugation

Unconjugated

Field of Research

Cancer Biology, Cell Biology, Metabolism Research

Purification

Immunogen affinity purified.

Concentration

Adding 0.2 ml of distilled water will yield a concentration of 500 μg/ml.

Dilution

Western blot, 0.1-0.5μg/ml, Human

Form

Lyophilized

Molecular Weight

55 kDa

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Notes

For research use only.

Tested Applications

WB

Host or Source

Rabbit

Preservative

Each vial contains antibody formulated with stabilizing components, 0.9 mg NaCl, 0.2 mg Na2HPO4, and 0.05 mg NaN3. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation method used. For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.